How The UK, EU, Canada, Australia And Japan Are Tackling Diversity In Clinical Trials

As efforts to improve diversity in clinical trials gain momentum globally, the Pink Sheet asked regulators in the UK, the EU, Canada, Australia and Japan about their efforts to support representative enrolment.